Fundraising Fox

Legacy

YC S19

New York City, US · Founded 2019 · 35 employees · 14 known investors

Legacy is a men's fertility and reproductive health company that provides sperm testing, analysis, and banking services. It draws on a medical and scientific advisory board of urologists, reproductive endocrinologists, and andrology researchers.

Also known as givelegacy.com · Legacy

Founders & leadership· Y Combinator alumni (S19)

Legacy was founded in 2019 by Khaled Kteily and Sarah Steinle.

KKKhaled Kteily
Khaled Kteilyin𝕏FounderKhaled Kteily is CEO of Legacy, a fertility-focused company that participated in Y Combinator's Summer 2019 cohort and has raised approximately $50 million from institutional and celebrity investors.
SSSarah Steinle
Sarah SteinleinFounder

Investors · 14

Company profile

researched Aug 2026

Legacy is a men's fertility and reproductive health company that sells mail-in kits for semen analysis and cryopreservation of sperm. Customers order a clinic-grade collection kit online without a doctor's visit, produce a sample at home, and ship it to Legacy's laboratory, where it is analyzed and, if suitable, frozen in liquid nitrogen vapor at -196°C. Results are delivered through a private online dashboard, and samples are stored long term across multiple cryogenic laboratories for redundancy. When a client is ready to use a stored sample for artificial insemination or IVF, the process can be initiated from the dashboard and Legacy coordinates the transfer of the sample to the client's healthcare provider.

The company positions the service around specific use cases, including couples trying to conceive, men planning a vasectomy, people undergoing gender-affirming care or testosterone therapy, patients facing cancer treatment, and members of the military or people in hazardous occupations. Legacy states that it turns samples around from checkout to lab in less than a week, which it describes as ten times faster than a traditional clinic, and that its pricing is more than 33% below clinic alternatives, with sperm freezing starting at $245 per year. It reports having performed more than 75,000 analyses and a 4.9 rating across more than 130 Google Business reviews.

Business model

Direct-to-consumer sale of at-home sperm testing kits and paid sperm cryopreservation, including a "Forever" freezing bundle, with recurring annual storage fees. Legacy states it is in network with most major insurance plans and benefits programs, and highlights eligibility pathways under which a customer may be able to freeze at no out-of-pocket cost.

Kit and analysis purchases plus subscription-style long-term storage fees (from $245 per year), supplemented by insurance and employer benefit reimbursement.

Traction

Reports more than 75,000 analyses performed and a 4.9 average rating from over 130 Google Business reviews.

Latest developments

The company is running a limited-time promotion advertising savings of over $1,400 on its Forever sperm freezing bundle.

Full profile — market position, technology, go-to-market

Market position

Positions itself as an online leader in male fertility testing and sperm freezing, framing its offer against traditional in-clinic andrology services.

Home collection avoids clinic appointments and communal collection rooms; the company cites turnaround from checkout to lab in under a week (described as 10x faster than a traditional clinic), pricing more than 33% below clinics, discreet packaging and private digital results, and redundant multi-site storage.

Technology

Mail-in clinic-grade collection kits paired with laboratory semen analysis, cryopreservation using liquid nitrogen vapors at -196°C, distributed storage across multiple cryo labs for risk mitigation, and a private virtual dashboard for results and for initiating sample transfers to clinics.

Go-to-market

Online direct-to-consumer funnel with a short recommendation quiz, discreetly packaged mail-order kits, promotional bundle discounts, telephone/customer-service-assisted purchasing, insurance and employer benefit coverage, customer testimonials, and physician commentary supporting mail-in screening.

Men and people with sperm seeking fertility testing or preservation: those trying to conceive, pre-vasectomy patients, people beginning gender-affirming hormone therapy or testosterone therapy, cancer patients facing gonadotoxic treatment, and military personnel or workers in dangerous jobs.

Compiled by commissioned research from 1 cited public sources — announcements, filings, and press listed under research sources below.

Key figures

latest reported
Google Business ratingJan 20254.9 stars
HeadcountAug 2026432
Semen analyses performed (cumulative)Jan 202575,000 analyses
Sperm freezing entry priceJan 2025$245

Company-reported or press-reported figures, each dated to when it was claimed — not independently audited.

Competitors · 3

by search overlap

Companies competing with Legacy for the same Google search keywords, organic and paid, via search-intersection analysis.

In the news

Research sources · 1

primary sources listed

1 public sources were cited for this profile; the first-party ones are listed here.

Frequently asked questions

What does Legacy do?
Legacy offers at-home sperm testing, analysis and long-term sperm freezing delivered by mail-in kit.
Who founded Legacy?
Legacy was founded by Khaled Kteily, Sarah Steinle in 2019.
Who are Legacy's investors?
Legacy's investors include AMK Investment Office, Oyster Ventures, Samsung Next, The MBA Fund, Tq Ventures Llc, TRAC (Third Round Analytics Capital), Valia Ventures, Valspring Capital and 6 more.
Where is Legacy headquartered?
Legacy is headquartered in New York City, US.